Literature DB >> 7724760

Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation.

R Y Kim1, J T Meyer, W E Plott, S A Spencer, R F Meredith, R L Jennelle, M M Salter.   

Abstract

PURPOSE: To evaluate major geometric variations in multiple intracavitary applications for carcinoma of the cervix.
MATERIALS AND METHODS: Orthogonal radiographs were reviewed of 17 consecutive patients with carcinoma of the cervix treated with 70 applications of high-dose-rate brachytherapy. In seven patients, conscious sedation was used for all applications. In 10 patients, general anesthesia was used for the first application and conscious sedation for subsequent applications. Major geometric variation between applications in axis, length, and slippage in tandem placement and separation, packing, and slippage in colpostats placement were reviewed. A major variation was defined as more than 1.0-cm deviation.
RESULTS: Major variations between applications occurred more commonly in colpostats placement than in tandem placement. For tandems, the rates of variation were 5.7% in axis, 4.3% in length, and 1.4% in slippage. For colpostats, rates of variation were 7.1% in separation, 25.7% in vaginal packing, and 7.1% in slippage. No consistent pattern of variation was found between applications except in vaginal packing.
CONCLUSION: Awareness of geometric variations should improve proper placement of intracavitary applicators for brachytherapy.

Entities:  

Mesh:

Year:  1995        PMID: 7724760     DOI: 10.1148/radiology.195.2.7724760

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Assessment of tumor regression by consecutive pelvic magnetic resonance imaging and dose modification during high-dose-rate brachytherapy for carcinoma of the uterine cervix.

Authors:  Taek-Keun Nam; Byung-Sik Nah; Ho-Sun Choi; Woong-Ki Chung; Sung-Ja Ahn; Seok-Mo Kim; Ju-Young Song; Mi-Seon Yoon
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

2.  Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients.

Authors:  Anil Kumar Talluri; Krishnam Raju Alluri; Deleep Kumar Gudipudi; Shabbir Ahamed; Madhusudhana M Sresty; Aparna Yarrama Reddy
Journal:  J Med Phys       Date:  2013-10

3.  Anatomic variation of prescription points and treatment volume with fractionated high-dose rate gynecological brachytherapy.

Authors:  Osman A Elhanafy; Rupak K Das; Bhudatt R Paliwal; Mostafa D Migahed; Hanim A Sakr; Mostafa Elleithy
Journal:  J Appl Clin Med Phys       Date:  2002       Impact factor: 2.102

4.  Interfraction Variations in Organ Filling and Their Impact on Dosimetry in CT Image Based HDR Intracavitary Brachytherapy.

Authors:  Ramya Rangarajan
Journal:  J Med Phys       Date:  2018 Jan-Mar

5.  Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.

Authors:  Gurubasappa Patil; Kiran Kumar Br; Geeta Narayanan
Journal:  Cureus       Date:  2022-01-22

6.  Interobserver variation in rectal and bladder doses in orthogonal film-based treatment planning of cancer of the uterine cervix.

Authors:  P Raghukumar; K Raghu Ram Nair; B Saju; G Zhenia; K T Divya; V S Shaiju; V Padmanabhan
Journal:  J Med Phys       Date:  2008-10

7.  Magnitude and Implications of Interfraction Variations in Organ Doses during High Dose Rate Brachytherapy of Cervix Cancer: A CT Based Planning Study.

Authors:  Santam Chakraborty; Firuza D Patel; Vijay M Patil; Arun S Oinam; Suresh C Sharma
Journal:  ISRN Oncol       Date:  2014-02-03

8.  Interfraction Variation and Dosimetric Changes in Patients With Cervical Cancer Treated With Intracavitary Brachytherapy.

Authors:  Jayson L Co; Maureen R Bojador; Michael Benedict A Mejia; Teresa T Sy Ortin; Domingo E Ganzon
Journal:  J Glob Oncol       Date:  2017-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.